Myasthenia gravis, MuSK antibody positive (Q88643): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
Property / Canary Token
 
dki-india-ID_422441512
Property / Canary Token: dki-india-ID_422441512 / rank
 
Normal rank

Revision as of 14:57, 15 August 2026

Approximately 50% of the Acetylcholine receptor-negative patients have autoantibodies against muscle-specific kinase (MuSK). MuSK MG is a separate disease entity given the characteristic pattern of weakness, disease course and pathophysiology. MuSK MG is 20 x as rare as AChR –positive MG (prevalence 1–2 per 10,000 persons). Most patients are female, have an onset <40 years, present with ptosis and diplopia, may rapidly develop bulbar weakness (oculobulbar presentation) and are at higher risk of respiratory crisis. One-third to half of MuSK MG patients may experience myasthenic crises requiring ventilatory support. Limb muscle weakness is less severe. Small thymomas have occasionally been reported.
Language Label Description Also known as
default for all languages
ID_422441512
    English
    Myasthenia gravis, MuSK antibody positive
    Approximately 50% of the Acetylcholine receptor-negative patients have autoantibodies against muscle-specific kinase (MuSK). MuSK MG is a separate disease entity given the characteristic pattern of weakness, disease course and pathophysiology. MuSK MG is 20 x as rare as AChR –positive MG (prevalence 1–2 per 10,000 persons). Most patients are female, have an onset <40 years, present with ptosis and diplopia, may rapidly develop bulbar weakness (oculobulbar presentation) and are at higher risk of respiratory crisis. One-third to half of MuSK MG patients may experience myasthenic crises requiring ventilatory support. Limb muscle weakness is less severe. Small thymomas have occasionally been reported.

      Statements

      CID11:ID_422441512
      0 references
      dki-india-ID_422441512
      0 references